US Food and Drug Administration (FDA) commissioner Martin Makary has announced that the IV fluid shortage for sodium chloride 0.9% injection products is now over after nearly a year of disruption.

In the first half (H1) of 2025, Abbott Laboratories performed well in the US medical device sector, with steady growth in its core product lines.

The US FDA has granted approval to Nyxoah’s Genio system for treating individuals with moderate to severe obstructive sleep apnoea (OSA).

UK-based EDX Medical has developed a test designed to identify and characterise the early signs of pneumonia in critically ill hospitalised patients.

Dana-Farber Cancer Institute has unveiled a new blood test that could change the way multiple myeloma (MM) and its precursor conditions.